Table 2.
Concentration of apolipoproteins (μg/dL) in the serum of patients with schizophrenia and healthy individuals (Me [Q1; Q3]).
| Healthy persons N = 25 | Patients with schizophrenia N = 53 | p-value | |
|---|---|---|---|
| ApoA1, μg/dL | 117.69 [48.81; 190.17] | 51.95 [39.53; 66.68] | 0.002* |
| ApoA2, μg/dL | 52.295 [41.835; 65.97] | 43.47 [28.26; 68.26] | 0.443 |
| ApoC2, μg/dL | 13.75 [10.89; 25.36] | 20.17 [9.43; 36.3] | 0.268 |
| ApoC3, μg/dL | 31.66 [23.16; 41.49] | 42.55 [20.865; 67.59] | 0.216 |
| ApoE, μg/dL | 4.655 [3.21; 6.12] | 4.6 [3.59; 5.87] | 0.911 |
Abbreviations: ApoA1, ApoA2, ApoC2, ApoC3, ApoE – apolipoproteins A1, A2, C2, C3, E.Comparisons between groups were performed using Mann-Whitney U-test. * - p < 0.05 – statistically significant difference (highlighted in bold).